Home » Markets » Bayer chairman quits as Roundup settlement talks progress
Bayer chairman quits as Roundup settlement talks progress
Bayer faces 4th cancer lawsuit over Roundup
A fourth lawsuit has been filed against Bayer for cancer allegedly associated with its Roundup weed killer. FOX Business’ Ashley Webster with more.
FRANKFURT (Reuters) – Bayer Chairman Werner Wenning, one of the architects of a $63 billion takeover deal that has left the German crop protection company fighting costly lawsuits, will step down in April, it said on Wednesday.
Continue Reading Below
Bayer shares have plunged about a quarter in value since August 2018, when the company lost the first U.S. lawsuit claiming weedkiller Roundup – acquired via the takeover of Monsanto – causes cancer.
"We have made and continue to make progress in handling the legal issues in the U.S. That's why now is a good time to hand over to my successor,'' the 73-year-old Wenning said in a statement.
Norbert Winkeljohann, who was head of auditing firm PricewaterhouseCoopers Europe SE until June 2018 and has been a member of Bayer's supervisory board since 2018, will succeed Wenning after the annual shareholders' meeting on April 28, the company added.
BAYER FACES FOURTH US ROUNDUP CANCER TRIAL IN MONSANTO HOME COURT
Wenning, whose term as chairman of Bayer's non-executive supervisory board would have expired in 2022, said he had originally intended to step down last year after reaching the board's recommended age limit of 72, but was asked to stay on.